What is the current Price Target for the Atara Biotherapeutics Inc stock?

The average Atara Biotherapeutics Inc target price is $17.34. This is 42.95% higher than the current stock price. The highest price target is 55.81%, the lowest is 33.22%. 5 Analysts have issued a price target Atara Biotherapeutics Inc 2026 .

How high will the Atara Biotherapeutics Inc stock rise?

No reliable answer can be given as to how high the Atara Biotherapeutics Inc stock will rise. The performance of stocks, including the Atara Biotherapeutics Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Atara Biotherapeutics Inc stock today?

The performance of Atara Biotherapeutics Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Atara Biotherapeutics Inc stock fall?

The decline in Atara Biotherapeutics Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Atara Biotherapeutics Inc Forecast, price target & analysts

$12.13

5.11% yesterday

Nasdaq, Aug 13, 10:00 pm CET

ISIN

US0465131078

Symbol

ATRA

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Atara Biotherapeutics Inc Target price 2025 - Analyst rating & recommendation

Atara Biotherapeutics Inc Classifications & Recommendation:

Buy

80%

Hold

20%

Atara Biotherapeutics Inc Price Target

Target Price	$17.34
Price	$12.13
Potential	42.95% register free of charge
Number of Estimates	5

	5 Analysts have issued a price target Atara Biotherapeutics Inc 2026 . The average Atara Biotherapeutics Inc target price is $17.34. This is 42.95% register free of charge higher than the current stock price. The highest price target is $18.90 55.81% register free of charge , the lowest is $16.16 33.22% register free of charge .
	A rating was issued by 10 analysts: 8 Analysts recommend Atara Biotherapeutics Inc to buy, 2 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Atara Biotherapeutics Inc stock has an average upside potential 2026 of 42.95% register free of charge . Most analysts recommend the Atara Biotherapeutics Inc stock at Purchase.

Sales and Margin forecast 2024, 2025 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2024 Estimates
Revenue Million $	128.94	117.50
	1,404.55%
EBITDA Margin	-56.83%	-57.29%
	98.16%
Net Margin	-66.23%	-11.46%
	97.94%

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2024 Estimates
Earnings Per Share $	-11.41	-2.27
	82.49%
P/E		negative
EV/Sales		0.96

Atara Biotherapeutics Inc...

Current Atara Biotherapeutics Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Canaccord Genuity	Locked ➜ Locked	Locked	Mar 11 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Jan 28 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Jan 22 2025
Canaccord Genuity	Locked ➜ Locked	Locked	Jan 17 2025
Rodman & Renshaw	Locked ➜ Locked	Locked	Dec 20 2024
Canaccord Genuity	Locked ➜ Locked	Locked	Nov 13 2024
HC Wainwright & Co.	Locked ➜ Locked	Locked	Aug 21 2024

Analyst Rating	Date
Locked Canaccord Genuity: Locked ➜ Locked	Mar 11 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Jan 28 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Jan 22 2025
Locked Canaccord Genuity: Locked ➜ Locked	Jan 17 2025
Locked Rodman & Renshaw: Locked ➜ Locked	Dec 20 2024
Locked Canaccord Genuity: Locked ➜ Locked	Nov 13 2024
Locked HC Wainwright & Co.: Locked ➜ Locked	Aug 21 2024

Discover more stocks with a high price target

Deutsche Telekom 27.63%

TUI 25.18%

BioNTech SE - ADR 24.36%

Alibaba Group Holding Ltd 24.23%

Microsoft 22.46%

Snowflake 19.16%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now